KLX 170 (Fenofibrate 54 mg)

Pill imprint KLX 170 has been identified as Fenofibrate 54 mg.

Fenofibrate is used in the treatment of hyperlipoproteinemia; hypertriglyceridemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iia, elevated ldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 54 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for KLX 170

Fenofibrate 54 mg KLX 170
Fenofibrate 54 mg KLX 170
Fenofibrate
Imprint:
KLX
170
Strength:
54 mg
Color:
Yellow
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Karalex Pharma
National Drug Code (NDC):
42043-0170
Inactive Ingredients:
betadex
silicon dioxide
calcium phosphate dihydrate dibasic
docusate sodium
sodium benzoate
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)